Historical Valuation
Avanos Medical Inc (AVNS) is now in the Fair zone, suggesting that its current forward PE ratio of 11.65 is considered Fairly compared with the five-year average of 18.14. The fair price of Avanos Medical Inc (AVNS) is between 11.99 to 24.63 according to relative valuation methord.
Relative Value
Fair Zone
11.99-24.63
Current Price：12.16
Fair
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
Avanos Medical Inc (AVNS) has a current Price-to-Book (P/B) ratio of 0.67. Compared to its 3-year average P/B ratio of 0.78 , the current P/B ratio is approximately -14.53% higher. Relative to its 5-year average P/B ratio of 0.97, the current P/B ratio is about -31.02% higher. Avanos Medical Inc (AVNS) has a Forward Free Cash Flow (FCF) yield of approximately 14.43%. Compared to its 3-year average FCF yield of 7.25%, the current FCF yield is approximately 99.05% lower. Relative to its 5-year average FCF yield of 5.58% , the current FCF yield is about 158.61% lower.
P/B
Median3y
0.78
Median5y
0.97
FCF Yield
Median3y
7.25
Median5y
5.58
Competitors Valuation Multiple
AI Analysis for AVNS
The average P/S ratio for AVNS competitors is 2.95, providing a benchmark for relative valuation. Avanos Medical Inc Corp (AVNS.N) exhibits a P/S ratio of 0.74, which is -74.87% above the industry average. Given its robust revenue growth of 4.34%, this premium appears unsustainable.
Performance Decomposition
AI Analysis for AVNS
1Y
3Y
5Y
Market capitalization of AVNS increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of AVNS in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is AVNS currently overvalued or undervalued?
Avanos Medical Inc (AVNS) is now in the Fair zone, suggesting that its current forward PE ratio of 11.65 is considered Fairly compared with the five-year average of 18.14. The fair price of Avanos Medical Inc (AVNS) is between 11.99 to 24.63 according to relative valuation methord.
What is Avanos Medical Inc (AVNS) fair value?
AVNS's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Avanos Medical Inc (AVNS) is between 11.99 to 24.63 according to relative valuation methord.
How does AVNS's valuation metrics compare to the industry average?
The average P/S ratio for AVNS's competitors is 2.95, providing a benchmark for relative valuation. Avanos Medical Inc Corp (AVNS) exhibits a P/S ratio of 0.74, which is -74.87% above the industry average. Given its robust revenue growth of 4.34%, this premium appears unsustainable.
What is the current P/B ratio for Avanos Medical Inc (AVNS) as of Jan 10 2026?
As of Jan 10 2026, Avanos Medical Inc (AVNS) has a P/B ratio of 0.67. This indicates that the market values AVNS at 0.67 times its book value.
What is the current FCF Yield for Avanos Medical Inc (AVNS) as of Jan 10 2026?
As of Jan 10 2026, Avanos Medical Inc (AVNS) has a FCF Yield of 14.43%. This means that for every dollar of Avanos Medical Inc’s market capitalization, the company generates 14.43 cents in free cash flow.
What is the current Forward P/E ratio for Avanos Medical Inc (AVNS) as of Jan 10 2026?
As of Jan 10 2026, Avanos Medical Inc (AVNS) has a Forward P/E ratio of 11.65. This means the market is willing to pay $11.65 for every dollar of Avanos Medical Inc’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Avanos Medical Inc (AVNS) as of Jan 10 2026?
As of Jan 10 2026, Avanos Medical Inc (AVNS) has a Forward P/S ratio of 0.74. This means the market is valuing AVNS at $0.74 for every dollar of expected revenue over the next 12 months.